Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2023. Start Trial.
Date Value
June 30, 2026 -9.063M
March 31, 2026 -8.247M
December 31, 2025 -7.067M
September 30, 2025 -6.880M
June 30, 2025 -6.465M
March 31, 2025 -6.282M
Date Value
December 31, 2024 -5.829M
September 30, 2024 -4.319M
June 30, 2024 -6.380M
March 31, 2024 -5.393M
December 31, 2023 -4.659M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Harrow, Inc. -13.08M
ANI Pharmaceuticals, Inc. 167.52M
Corcept Therapeutics, Inc. 106.92M
Veru, Inc. -26.04M
Johnson & Johnson 19.98B